Staff editor
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
Industry
Sponsored by
This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.
Industry
Sponsored by
Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.
This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.
Scientific research, Video
Sponsored by
An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).
